Title: Study of everolimus with hormone therapy in women with high-risk breast cancer (ER-positive, HER2-negative) who are disease-free after initial treatment

Registered drug

Title: Study of everolimus with hormone therapy in women with high-risk breast cancer (ER-positive, HER2-negative) who are disease-free after initial treatment

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Everolimus
Sponsor:Unicancer

Contact Research Centre

Gastric cancer+2

Not recruiting

Study of Domvanalimab, Zimberelimab, and Chemotherapy for Patients with Advanced Esophageal or Gastric Cancer

Registered drugNo placebo

Study of Domvanalimab, Zimberelimab, and Chemotherapy for Patients with Advanced Esophageal or Gastric Cancer

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Calcium Folinate
Sponsor:Arcus Biosciences Inc.

Contact Research Centre

Substances studied in this area

The therapies tested most often in Neoplasms benign, malignant and unspecified (incl cysts and polyps) trials.

Pembrolizumab462 clinical trials Carboplatin340 clinical trials Cisplatin285 clinical trials Paclitaxel263 clinical trials Fluorouracil237 clinical trials Oxaliplatin227 clinical trials Nivolumab217 clinical trials Dexamethasone169 clinical trials Bevacizumab163 clinical trials

Neoplasms benign, malignant and unspecified (incl cysts and polyps) – page 207

Conditions in this area

Clinical trials in Neoplasms benign, malignant and unspecified (incl cysts and polyps)

3 898 clinical trials

Squamous cell carcinoma of head and neck

Study of petosemtamab compared to standard therapy in previously treated patients with metastatic or recurrent head and neck cancer

Squamous cell carcinoma of head and neck

Study of Niraparib and Dostarlimab with Radiotherapy for Patients with Locally-Advanced Head and Neck Cancer

Triple negative breast cancer

Study on Darolutamide and Capecitabine for Patients with Advanced Triple-Negative Androgen Receptor Positive Breast Cancer

Squamous cell carcinoma of head and neck

Study Comparing Radiotherapy Alone to Radiotherapy with Cisplatin for Patients with Sinus or Salivary Gland Tumors

Hormone-refractory prostate cancer

Study of Cabozantinib and Atezolizumab Compared to Hormonal Therapy in Adults with Metastatic Castration-Resistant Prostate Cancer

Plasma cell myeloma

Study of Belantamab Mafodotin Alone and with Drug Combination for Patients with Relapsed/Refractory Multiple Myeloma

Pleural mesothelioma malignant

Study of Pembrolizumab with Cisplatin or Carboplatin and Pemetrexed for Patients with Resectable Malignant Pleural Mesothelioma

Neoplasm

Study on Atezolizumab and Resiquimod Sulfate with Radiotherapy for Patients with Advanced Solid Tumors

Haematological malignancy

Study of Fibrinogen Treatment for Bleeding in Patients with Blood Cancer and Low Platelet Count Who Do Not Respond to Platelet Transfusions

Malignant fibrous histiocytoma+1

Study on Pembrolizumab and Olaparib for Patients with Resectable Soft Tissue Sarcoma

Hormone receptor positive HER2 negative breast cancer

Title: Study of everolimus with hormone therapy in women with high-risk breast cancer (ER-positive, HER2-negative) who are disease-free after initial treatment

Gastric cancer+2

Study of Domvanalimab, Zimberelimab, and Chemotherapy for Patients with Advanced Esophageal or Gastric Cancer

Filter the trials

Substances studied in this area

Prefer not to search? Our Concierge searches the trials for you.